Skip to main content
. Author manuscript; available in PMC: 2021 Nov 3.
Published in final edited form as: Radiother Oncol. 2019 Sep 26;142:124–132. doi: 10.1016/j.radonc.2019.09.010

Table 1.

Patient and target characteristics

Patient
number
Types Age
(years)
Disease
Stage
PCT ACT2
CTV1
(cm3)
CTV2
(cm3)
CTV3
(cm3)
Weight
(kg)
Fractions
between PCT
and ACT1
CTV1
(cm3)
CTV2
(cm3)
CTV3
(cm3)
Weight
(kg)
Fractions
between ACT1
and ACT2
CTV1
(cm3)
CTV2
(cm3)
CTV3
(cm3)
Weight
(kg)
Fractions
after
ACT2
1 nasopharynx 44 T2N2 166.4 318.5 109.1 50 13 166.1 317.7 110.4 49 12 164.8 319.9 110.8 47 8
2 nasopharynx 51 T4N1 161.4 296.6 121.4 59 8 163.4 322.9 125.4 59 17 164.1 312.1 117.9 54 8
3 nasopharynx 59 T4N1 148.5 214.0 53.8 62.5 11 148.5 206.4 54.7 60 14 141.5 216.2 47.2 59.5 8
4 nasopharynx 32 T4N1 172.5 147.5 69.8 61 13 176.5 140.1 72.3 59 12 172.6 146.1 69.9 57 8
5 oropharynx 19 T2N2 203.6 324.5 97.8 56 13 201.0 325.6 98.4 52.3 12 199.0 322.0 93.7 53 8
6 oropharynx 55 T4N2 306.2 523.2 216.4 121 12 318.6 535.7 206.7 118 13 270.9 484.5 205.9 113.4 8
7 oropharynx 18 T2N1 142.3 119.8 222.1 81.6 14 141.0 121.8 234.8 81 11 137.8 107.8 215.0 77.3 8
8 oropharynx 53 T1N2 257.7 483.2 244.9 114.5 11 250.1 465.9 254.4 113.3 14 259.3 484.3 239.0 115.5 8
9 nasopharynx 43 T4N1 260.5 570.8 298.5 115.5 11 264.4 571.1 310.8 113.7 14 259.8 552.9 311.9 110.3 8
10 nasopharynx 50 T4N2 170.4 385.9 256.9 84.2 12 171.1 387.5 260.5 85 13 173.5 387.2 252.6 82.4 8

Abbreviations: PCT = primary planning CT; CTV1 = clinical target volume 1; CTV2 = clinical target volume 2; CTV3 = clinical target volume 3; ACT1 = first adaptive planning CT; ACT2 = second adaptive planning CT.